Jean charles soria biography channels

          WHO Global #Cancer Observatory just released it's latest update.!

          Jean-Charles Soria is a Professor of Medicine and Medical Oncology at South-Paris University.

          Soria is credited with first-in-human work on a pair of key PD-(L)1s, pembrolizumab and atezolizumab.

        1. Jean-Charles Soria, M.D., Ph.D., is Professor of Medicine and Medical Oncology at the University of Paris-Saclay and currently serves as Director General of the.
        2. WHO Global #Cancer Observatory just released it's latest update.
        3. Professor Soria is currently head of the phase I programme at Institut Gustave Roussy and a member of the lung cancer unit with a focus on targeted therapies.
        4. He was clinical Director for Lung Cancer for Greater Manchester Cancer from and Appointed as Associate Medical Director for the Greater Manchester.

          5. He is a tenure-track and full-time cancer specialist at Institut Gustave Roussy. Dr Soria trained as a medical oncologist and obtained the Silver medal from Paris Medical School in 1997. He gained a PhD degree in the fundamental basis of oncogenesis in 2001, and completed his training with a two-year post-doctoral fellowship in the Department of Thoracic Head and Neck Medical Oncology at MD Anderson Cancer Center, Houston, USA, where he has held an Adjunct Professorship since 2012.

          Professor Soria is currently Chair of Drug Development Department at Gustave Roussy Cancer Center in Paris and is a member of the lung cancer unit with a focus on targeted therapies.

          His main research interests are: early clinical development, phase I trials across solid tumors, pharmacodynamic biomarkers, lung cancer and personalised medicine. He is also involved in translational research aspects related to pre